IL21 and Autoimmunity: Although the mechanism of secondary autoimmunity is not yet established, increased expression of B-cell activating factor (BAFF) in patients post-treatment, and the elevation of serum IL-21 in patients who develop autoimmunity, both of which are important factors for B cell differentiation and antibody production, support a B cell driven mechanism (59, 60).